6,674 results on '"Medical research -- Health aspects"'
Search Results
2. Gilead announces PURPOSE 2 met efficacy endpoints, reduced HIV infections by 96%
3. Seres Therapeutics reports data from Cohort 2 of SER-155 Phase 1b study
4. BIPOLAR ANDROGEN THERAPY IN PROSTATE CANCER: Current evidence and next steps
5. NanoViricides provides update on NV-387 pathway
6. In Oceanside, Mount Sinai South Nassau scores $1M donation
7. Rising to the Occasion: Substantiating Claims for Women's Health Products: Consumers and regulators expect the nutraceuticals industry to validate products with reliable scientific evidence
8. Could mRNA vaccines conquer another deadly infection? Researchers say yes
9. CWRU lands $2.6M grant to study blood pressure meds
10. Home-care nurses often have no idea their patients were hospitalized for sepsis. Penn nurses want to change that
11. Serious infections linked to dementia risk, study shows
12. MaineHealth to participate in major chronic Lyme study
13. Kids and teens who get covid more prone to diabetes, study finds
14. Life expectancy went up globally from 1990 to 2021, report shows
15. Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK
16. Creative Diagnostics Announces New Coronavirus Animal Model for Drug Discovery
17. Pennington Biomedical's EAT2 Study to Explore Unknown Effects of Weight Fluctuations
18. Methicillin-resistant Staphylococcus aureus (MRSA) Infection Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
19. Lupus Foundation of America Awards New Grant Supporting Research to Predict and Prevent Lupus in At-Risk Populations
20. Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit
21. Irritable Bowel Syndrome Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, MOA, ROA by DelveInsight | P4 Microbiome, Biomica, Invea Therapeutics, RaQualia Pharma, RedHill Biopharma
22. Every Cure Announces Leaders in Drug Development Joining its Executive Team
23. Cancer Therapy: AOP Health Investigates a New Approach Targeting Cancer Stem Cells
24. Establishment Labs Receives U.S. FDA Approval for Motiva Implants
25. New Data at AFS 2024 Demonstrates the Strength of Castle Biosciences' TissueCypher[R] Test in Independently Predicting Risk of Developing Esophageal Cancer, Guiding Risk-Aligned Management Decisions for Patients with Barrett's Esophagus
26. Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier Cancer Trial
27. Senhwa Biosciences Presents Clinical Data Abstract on Pidnarulex at 2024 ESMO Congress
28. Crestone Announces Positive Data From Phase 2 Clinical Trial of CRS3123 for C. Difficile Infections (CDI)
29. Wolters Kluwer provides free access to mpox resources for front-line clinicians, epidemiologists, and medical researchers
30. Global Heart Hub's Insights from Patients living with Elevated Cholesterol reveals the Importance of Shared Decision-Making
31. SUPPLEMENT SNAPSHOT: Vitamin D and Respiratory Tract Infections: Recent research on vitamin D supplementation and respiratory tract infections can help guide pharmacists in counseling patients
32. Outpatient C. diff infections may be underdiagnosed, study finds
33. Incident COVID-19 infections before Omicron in the U.S
34. Findings from Washington University Update Knowledge of COVID-19 (Sequential Early-life Viral Infections Modulate the Microbiota and Adaptive Immune Responses To Systemic and Mucosal Vaccination)
35. Findings from Ohio State University in Infectious Diseases and Conditions Reported (A Novel Bayesian Spatio-temporal Surveillance Metric To Predict Emerging Infectious Disease Areas of High Disease Risk)
36. Study Data from University of Pecs Update Understanding of COVID-19 (Non-conventional Prognostic Markers In Life-threatening Covid-19 Cases-when Less Is More)
37. New Vaccination Data Have Been Reported by Researchers at National Center for Immunization and Respiratory Diseases (Vaccination Coverage By Age 24 Months Among Children Born During 2017-2021-us-affiliated Pacific Islands)
38. Estimating the generation time for SARS-CoV-2 transmission using household data in the United States, December 2021 - May 2023
39. Findings from Department of Urology Update Knowledge of Prostate Cancer (Predictors of Recurrence After Metastasis-directed Therapy In Oligorecurrent Prostate Cancer Following Radical Prostatectomy)
40. AMRA Study Published in Obesity Links Antidepressant Use with Poor Muscle Health, Increased Cardiometabolic Risk
41. Studies from Massachusetts General Hospital Yield New Data on COVID-19 (Predictors of Covid-19 Infection and Hospitalization In Group Homes for Individuals With Intellectual And/or Developmental Disabilities)
42. Recent Findings from Centers for Disease Control and Prevention Has Provided New Information about Lyme Disease (Pregnancy Among Reported Lyme Disease Cases-united States, 1992-2019)
43. Studies from Yale University School of Public Health Reveal New Findings on COVID-19 (Genome-wide Association Study Between Sars-cov-2 Single Nucleotide Polymorphisms and Virus Copies During Infections)
44. Researchers at Pontchaillou University Hospital Report New Data on COVID-19 (Neutrophil Phenotype, Effector Functions, and Microbicidal Activity In Patients With Sars-cov-2-associated Ards)
45. New COVID-19 Study Findings Recently Were Reported by Researchers at Griffith University (The Impact of Vaccination On the Likelihood of Covid-19 Infection)
46. Reports from Sapienza University of Rome Highlight Recent Findings in COVID-19 (Impact of Anti-sars-cov-2 Monoclonal Antibodies In the Management of Patients With Lymphoma and Covid19: a Retrospective Study)
47. Prevalence of common respiratory viruses in children: insights from post-pandemic surveillance
48. New Findings Reported from Thammasat University Describe Advances in COVID-19 (Immunogenicity During 6 Months After Sars-cov-2 Infection Is Significantly Different Depending On Previous Covid-19 Vaccine Regimens and a Booster Dose Received)
49. Data on COVID-19 Described by Researchers at Robert Koch Institute (Bus Riding As Amplification Mechanism for Sars-cov-2 Transmission, Germany, 20211)
50. Reports from 'Alexandru Ioan Cuza' University Add New Data to Findings in COVID-19 (Death Obsession, Covid-19-related Fear and Religiosity In People Living With Type 2 Diabetes)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.